On July 19, 2021, Digital Therapeutics, Inc. closed the transaction. The company has received $64,000,000 oversubscribed round of funding co-led by new investors Atomico Investment Holdings Limited and Kinnevik AB. The transaction also included participation from returning investors Triple Point Investment Management LLP, StartUp Health, LLC, Octopus Ventures Ltd. The company has issued $49,499,929 pursuant to exemption provided under Regulation D from 6 investors.